Variant report
Variant | nsv465770 |
---|---|
Chromosome Location | chr8:114853127-114897615 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6992411 | chr8:114870236-114870237 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529324481 | chr8:114870238-114870239 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535080031 | chr8:114870279-114870280 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146884923 | chr8:114870297-114870298 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554871054 | chr8:114870330-114870331 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544248599 | chr8:114870351-114870352 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139277807 | chr8:114870360-114870361 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572820641 | chr8:114870376-114870377 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568399501 | chr8:114870377-114870378 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
10 | rs9886433 | chr8:114879021-114879022 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs534997403 | chr8:114879049-114879050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551422982 | chr8:114879113-114879114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145791989 | chr8:114879187-114879188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536871666 | chr8:114879216-114879217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556694442 | chr8:114879324-114879325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542880428 | chr8:114879354-114879355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190232349 | chr8:114879387-114879388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181936637 | chr8:114879419-114879420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562549139 | chr8:114879485-114879486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184513307 | chr8:114879488-114879489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531584716 | chr8:114879557-114879558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572782056 | chr8:114879570-114879571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551410804 | chr8:114879573-114879574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544952945 | chr8:114879596-114879597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564791188 | chr8:114879612-114879613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs578237962 | chr8:114879629-114879630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544039985 | chr8:114879639-114879640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571189307 | chr8:114879714-114879715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189221983 | chr8:114879739-114879740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181196319 | chr8:114879779-114879780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369990092 | chr8:114879803-114879804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185798415 | chr8:114879864-114879865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191508595 | chr8:114879904-114879905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551725669 | chr8:114879925-114879926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571214489 | chr8:114879957-114879958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373052735 | chr8:114879965-114879966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536909228 | chr8:114879976-114879977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73334978 | chr8:114879988-114879989 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs180735914 | chr8:114879995-114879996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs72677707 | chr8:114880005-114880006 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs115940137 | chr8:114880060-114880061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs138684793 | chr8:114880086-114880087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7017435 | chr8:114880103-114880104 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs186118503 | chr8:114880108-114880109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552973216 | chr8:114880126-114880127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11461921 | chr8:114880182-114880183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs398112901 | chr8:114880184-114880185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs200791055 | chr8:114880185-114880186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538496286 | chr8:114880196-114880197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78193701 | chr8:114881410-114881411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Schizophrenia | 20967226 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:114870200-114870400 | Flanking Bivalent TSS/Enh | Pancreas | Pancrea |
2 | chr8:114879000-114880200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr8:114879200-114880000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr8:114879600-114880000 | Enhancers | Dnd41 | blood |
5 | chr8:114879600-114880200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr8:114881400-114882200 | Enhancers | HUVEC | blood vessel |